What is it about?
We showed Pyogenic granuloma that the patient was treated with ramucirumab. During the administration of the angiogenesis inhibitor ramucirumab, PG has been growth.
Featured Image
Read the Original
This page is a summary of: Development of pyogenic granuloma with strong vascular endothelial growth factor receptor-2 expression during ramucirumab treatment, BMJ Case Reports, November 2019, BMJ,
DOI: 10.1136/bcr-2019-231464.
You can read the full text:
Contributors
The following have contributed to this page
